* unstable angina; within 6 months of myocardial infarction; decompensated cardiac failure (unless under close medical supervision); severe arrhythmias; congenital or acquired heart-valve defects; within 3 months of cerebrovascular events; pulmonary veno-occlusive disease; conditions which increase risk of bleeding.
Iloprost
Carboprost
Latanoprost
Travoprost
Mometasone
Beclometasone
Latanoprostene bunod
Ibotenic acid